Exendin-4 protects hypoxic islets from oxidative stress and improves islet transplantation outcome

Endocrinology

Volumn 154, Issue 4, 2013, Pages 1424-1433

  Padmasekar, M ^a   Lingwal, N ^a   Samikannu, B ^a   Chen, C ^a   Sauer, H ^b   Linn, T ^a,c  

^a UNIVERSITY HOSPITAL GIESSEN   (Germany)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

^c Clinical Research Unit   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EXENDIN 4; INSULIN; INTERLEUKIN 1BETA; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DIABETIC PATIENT; ENZYME PHOSPHORYLATION; FEMALE; HYPOXIA; INSULIN RELEASE; NONHUMAN; OUTCOME ASSESSMENT; OXIDATIVE STRESS; PANCREAS ISLET; PANCREAS ISLET BETA CELL; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; SURVIVAL; SWINE;

ANIMALS; APOPTOSIS; CELL HYPOXIA; CELLS, CULTURED; DIABETES MELLITUS, EXPERIMENTAL; DISEASE MODELS, ANIMAL; GRAFT SURVIVAL; HYPOGLYCEMIC AGENTS; INSULIN-SECRETING CELLS; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; MICE; MICE, INBRED C57BL; OXIDATIVE STRESS; PEPTIDES; REACTIVE OXYGEN SPECIES; SWINE; VENOMS;

EID: 84875853013     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2012-1983     Document Type: Article

References (56)

1. Tiedge M, Lortz S, Drinkgern J, Lenzen S. Relation between antioxidant enzyme gene expression and antioxidative defense status of insulin-producing cells. Diabetes. 1997;46:1733-1742.
2. Rao P, Maeda H, Yutong X, Yamamoto M, Hirose N, Sasaguri S. Protective effect of a radical scavenger, MCI-186 on islet cell damages induced by oxidative stress. Transplant Proc. 2005;37:3457-3458.
3. Mancarella R, Del Guerra S, Masini M, et al. Beneficial effect of the nonpeptidyl low molecular weight radical scavenger IAC on cultured human islet function. Cell Transplant. 2008;17:1271-1276.
4. Mahato RI, Henry J, Narang AS, et al. Cationic lipid and polymerbased gene delivery to human pancreatic islets. Mol Ther. 2003;7: 89-100.
5. Cheng K, Fraga D, Zhang C, et al. Adenovirus-based vascular endothelial growth factor gene delivery to human pancreatic islets. Gene Ther. 2004;11:1105-1116.
6. Narang AS, Cheng K, Henry J, et al. Vascular endothelial growth factor gene delivery for revascularization in transplanted human islets. Pharm Res. 2004;21:15-25.
7. Narang AS, Sabek O, Gaber AO, Mahato RI. Co-expression of vascular endothelial growth factor and interleukin-1 receptor antagonist improves human islet survival and function. Pharm Res. 2006; 23:1970-1982.
8. Chen XB, Li YX, Jiao Y, et al. Influence of heme oxygenase-1 gene transfer on the viability and function of rat islets in in vitro culture. World J Gastroenterol. 2007;13:1053-1059.
9. Bertera S, Crawford ML, Alexander AM, et al. Gene transfer of manganese superoxide dismutase extends islet graft function in a mouse model of autoimmune diabetes. Diabetes. 2003;52:387-393.
10. Mysore TB, Shinkel TA, Collins J, et al. Overexpression of glutathione peroxidase with two isoforms of superoxide dismutase protects mouse islets from oxidative injury and improves islet graft function. Diabetes. 2005;54:2109-2116.
11. Holst JJ. Glucagonlike peptide 1: a newly discovered gastrointestinal hormone. Gastroenterology. 1994;107:1848-1855.
12. Goke R, Fehmann HC, Linn T, et al. Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin-secreting β-cells. J Biol Chem. 1993;268:19650-19655.
13. Eng J, Kleinman WA, Singh L, Singh G, Raufman JP. Isolation and characterization of exendin-4, an exendin-3 analogue, from Heloderma suspectum venom. Further evidence for an exendin receptor on dispersed acini from guinea pig pancreas. J Biol Chem. 1992; 267:7402-7405.
14. Parkes DG, Pittner R, Jodka C, Smith P, Young A. Insulinotropic actions of exendin-4 and glucagon-like peptide-1 in vivo and in vitro. Metabolism. 2001;50:583-589.
15. Xue S, Wasserfall C, Parker M, et al. Exendin-4 treatment of nonobese diabetic mice increases β-cell proliferation and fractional insulin reactive area. J Diabetes Complications. 2010;24:163-167.
16. Song WJ, Schreiber WE, Zhong E, et al. Exendin-4 stimulation of cyclin A2 in β-cell proliferation. Diabetes. 2008;57:2371-2381.
17. Park S, Dong X, Fisher TL, et al. Exendin-4 uses Irs2 signaling to mediate pancreatic β-cell growth and function. J Biol Chem. 2006; 281:1159-1168.
18. Xu G, Stoffers DA, Habener JF, Bonner-Weir S. Exendin-4 stimulates both β-cell replication and neogenesis, resulting in increased β-cell mass and improved glucose tolerance in diabetic rats. Diabetes. 1999;48:2270-2276.
19. Chen J, Couto FM, Minn AH, Shalev A. Exenatide inhibits β-cell apoptosis by decreasing thioredoxin-interacting protein. Biochem Biophys Res Commun. 2006;346:1067-1074.
20. Tews D, Lehr S, Hartwig S, Osmers A, Paslack W, Eckel J. Antiapoptotic action of exendin-4 in INS-1 β cells: comparative protein pattern analysis of isolated mitochondria. Horm Metab Res. 2009; 41:294-301.
21. Tsunekawa S, Yamamoto N, Tsukamoto K, et al. Protection of pancreatic β-cells by exendin-4 may involve the reduction of endoplasmic reticulum stress; in vivo and in vitro studies. J Endocrinol. 2007;193:65-74.
22. Liu LB, Wang YP, Pan XD, Jiang SY, Chen Z. Exendin-4 protected murine MIN6 pancreatic β-cells from oxidative stress-induced apoptosis via down-regulation of NF-κB-iNOS-NO pathway [in Chinese]. Yao Xue Xue Bao. 2008;43:690-694.
23. 2-terminal kinase pathway. Diabetes. 2008;57:1205-1215.
24. Velmurugan K, Balamurugan AN, Loganathan G, Ahmad A, Hering BJ, Pugazhenthi S. Antiapoptotic actions of exendin-4 against hypoxia and cytokines are augmented by CREB. Endocrinology. 2012;153:1116-1128.
25. Cechin SR, Perez-Alvarez I, Fenjves E, et al. Anti-inflammatory properties of exenatide in human pancreatic islets. Cell Transplant. 2012;21:633-648.
26. Crutchlow MF, Yu M, Bae YS, Deng S, Stoffers DA. Exendin-4 does not promote β-cell proliferation or survival during the early postislet transplant period in mice. Transplant Proc. 2008;40:1650-1657.
27. King A, Lock J, Xu G, Bonner-Weir S, Weir GC. Islet transplantation outcomes in mice are better with fresh islets and exendin-4 treatment. Diabetologia. 2005;48:2074-2079.
28. Juang JH, Kuo CH, Wu CH, Juang C. Exendin-4 treatment expands graftβ-cell mass in diabetic mice transplanted with a marginal number of fresh islets. Cell Transplant. 2008;17:641-647.
29. Toyoda K, Okitsu T, Yamane S, et al. GLP-1 receptor signaling protects pancreatic β cells in intraportal islet transplant by inhibiting apoptosis. Biochem Biophys Res Commun. 2008;367:793-798.
30. Brown SB, Libonati JR, Selak MA, Shannon RP, Simmons RA. Neonatal exendin-4 leads to protection from reperfusion injury and reduced rates of oxidative phosphorylation in the adult rat heart. Cardiovasc Drugs Ther. 2010;24:197-205.
31. Teramoto S, Miyamoto N, Yatomi K, et al. Exendin-4, a glucagonlike peptide-1 receptor agonist, provides neuroprotection in mice transient focal cerebral ischemia. J Cereb Blood Flow Metab. 2011; 31:1696-1705.
32. Toso C, Oberholzer J, Ris F, et al. Factors affecting human islet of Langerhans isolation yields. Transplant Proc. 2002;34:826-827.
33. Brandhorst D, Huettler S, Alt A, et al. Adjustment of the ratio between collagenase class II and I improves islet isolation outcome. Transplant Proc. 2005;37:3450-3451.
34. Lai Y, Schneider D, Kidszun A, et al. Vascular endothelial growth factor increases functional β-cell mass by improvement of angiogenesis of isolated human and murine pancreatic islets. Transplantation. 2005;79:1530-1536.
35. Lenzen S, Drinkgern J, Tiedge M. Low antioxidant enzyme gene expression in pancreatic islets compared with various other mouse tissues. Free Radic Biol Med. 1996;20:463-466.
36. Bottino R, Balamurugan AN, Tse H, et al. Response of human islets to isolation stress and the effect of antioxidant treatment. Diabetes. 2004;53:2559-2568.
37. Gedulin BR, Nikoulina SE, Smith PA, et al. Exenatide (exendin-4) improves insulin sensitivity andβ-cell mass in insulin-resistant obese fa/fa Zucker rats independent of glycemia and body weight. Endocrinology. 2005;146:2069-2076.
38. Rother KI, Harlan DM. Challenges facing islet transplantation for the treatment of type 1 diabetes mellitus. J Clin Invest. 2004;114: 877-883.
39. Li Y, Hansotia T, Yusta B, Ris F, Halban PA, Drucker DJ. Glucagonlike peptide-1 receptor signaling modulates β-cell apoptosis. J Biol Chem. 2003;278:471-478.
40. Saitoh M, Nishitoh H, Fujii M, et al. Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. EMBO J. 1998;17:2596-2606.
41. Enoksson M, Fernandes AP, Prast S, Lillig CH, Holmgren A, Orrenius S. Overexpression of glutaredoxin 2 attenuates apoptosis by preventing cytochrome c release. Biochem Biophys Res Commun. 2005;327:774-779.
42. Chou FC, Sytwu HK. Overexpression of thioredoxin in islets transduced by a lentiviral vector prolongs graft survival in autoimmune diabetic NOD mice. J Biomed Sci. 2009;16:71.
43. Robertson RP, Harmon JS. Diabetes, glucose toxicity, and oxidative stress: A case of double jeopardy for the pancreatic islet β-cell. Free Radic Biol Med. 2006;41:177-184.
44. Martens GA, Cai Y, Hinke S, Stange G, Van de Casteele M, Pipeleers D. Glucose suppresses superoxide generation in metabolically responsive pancreatic β-cells. J Biol Chem. 2005;280:20389-20396.
45. Guzy RD, Schumacker PT. Oxygensensing by mitochondria at complex III: the paradox of increased reactive oxygen species during hypoxia. Exp Physiol. 2006;91:807-819.
46. m) in pancreatic RINm5F cells: prevention by Bcl-2. Mol Cell Endocrinol. 2002;190:75-82.
47. Robertson RP, Harmon J, Tran PO, Tanaka Y, Takahashi H. Glucose toxicity in β-cells: type 2 diabetes, good radicals gone bad, and the glutathione connection. Diabetes. 2003;52:581-587.
48. Mohseni Salehi Monfared SS, Larijani B, Abdollahi M. Islet transplantation and antioxidant management: a comprehensive review. World J Gastroenterol. 2009;15:1153-1161.
49. Mukai E, Fujimoto S, Sato H, et al. Exendin-4 suppresses SRC activation and reactive oxygen species production in diabetic Goto-Kakizaki rat islets in an Epac-dependent manner. Diabetes. 2011; 60:218-226.
50. Sato Y, Endo H, Okuyama H, et al. Cellular hypoxia of pancreatic β-cells due to high levels of oxygen consumption for insulin secretion in vitro. J Biol Chem. 2011;286:12524-12532.
51. Pileggi A, Ricordi C, Alessiani M, Inverardi L. Factors influencing islet of Langerhans graft function and monitoring. Clin Chim Acta. 2001;310:3-16.
52. Narimiya M, Yamada H, Matsuba I, Ikeda YU, Tanese T, Abe M. The effect of hypoxia on insulin and glucagon secretion in the perfused pancreas of the rat. Endocrinology. 1982;111:1010-1014.
53. Dillon JS, Lu M, Bowen S, Homan LL. The recombinant rat glucagon-like peptide-1 receptor, expressed in an β-cell line, is coupled to adenylyl cyclase activation and intracellular calcium release. Exp Clin Endocrinol Diabetes. 2005;113:182-189.
54. Holz GG. Epac: a new cAMP-binding protein in support of glucagon-like peptide-1 receptor-mediated signal transduction in the pancreatic β-cell. Diabetes. 2004;53:5-13.
55. Li L, El-Kholy W, Rhodes CJ, Brubaker PL. Glucagon-like peptide-1 protects β cells from cytokine-induced apoptosis and necrosis: role of protein kinase B. Diabetologia. 2005;48:1339-1349.
56. Peyot ML, Gray JP, Lamontagne J, et al. Glucagon-like peptide-1 induced signaling and insulin secretion do not drive fuel and energy metabolism in primary rodent pancreatic β-cells. PLoS One. 2009; 4:e6221.